BrainStorm Details Phase 3 Trial Design of NurOwn for Rapidly Progressing ALS
BrainStorm Cell Therapeutics is sharing the details of the design of its Phase 3 clinical…
Articles by Steve Bryson, PhD
MDA Issues $1.6M in Grants to Boost ALS Research
The Muscular Dystrophy Association (MDA) has awarded five new grants totaling more than…
Saphyr Technology First to Measure DNA Expansions in Key ALS Gene
Saphyr, an ultra-long DNA analysis technology by Bionano Genomics, is the first to successfully…
Large Genetic Analysis Newly Links 5 Genes to Sporadic ALS
A combined analysis using people of Japanese, Chinese, and European ancestry identified five new genes associated with the…
Aural Analytics’ Speech Technology Added to HEALEY ALS Platform Trial
Aural Analytics’ speech-based digital technology will be used to measure changes in speech in people…
Stem Cell Treatment Seen to Safely Aid Speech in ALS Patients in Small Study
Stem cells collected from a patient’s bone marrow and infused into the spinal fluid safely improved speaking abilities…
Study Probes Gut Microbiome Alterations, Probiotics in ALS Patients
The gut microbiome in people with amyotrophic lateral sclerosis (ALS) is altered compared…
Common Blood Biomarker Changes Linked to ALS Progression, Study Determines
Changes in commonly tested blood biomarkers in people with amyotrophic lateral sclerosis (ALS)…
Slower Progression Seen in US Veterans Living Longer Than Disease Norm
A comparison of amyotrophic lateral sclerosis (ALS) among U.S. military veterans found those who lived the longest…
FAIM Protein Prevents, Reverses Mutant SOD1 Clumping, Study Shows
A molecule that prevents cell death was able to prevent and reverse clumping of a mutant form of…